Last reviewed · How we verify
Recurrent Mucocutaneous Herpes Simplex
Approved treatments
- Aciclovir · Assistance Publique Hopitaux De Marseille
- Zovirax · Ligand Pharms
Acyclovir works by mimicking a building block of DNA to prevent the herpes virus from replicating. - ACYC · Ligand Pharms
Acyc works by binding to a specific target in the body, although its exact mechanism is unknown.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Recurrent Mucocutaneous Herpes Simplex patent landscape — cliff calendar, originator estates, attackable patents
- Recurrent Mucocutaneous Herpes Simplex treatment landscape brief
- Recurrent Mucocutaneous Herpes Simplex treatment updates RSS
Frequently asked questions about Recurrent Mucocutaneous Herpes Simplex
What drugs treat Recurrent Mucocutaneous Herpes Simplex?
Tracked treatments include Aciclovir, Zovirax, ACYC.
What is the treatment for Recurrent Mucocutaneous Herpes Simplex?
Standard treatment for Recurrent Mucocutaneous Herpes Simplex includes Aciclovir, Zovirax, ACYC. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Recurrent Mucocutaneous Herpes Simplex patent cliff · Recurrent Mucocutaneous Herpes Simplex CI report
- Treatment: Aciclovir · Assistance Publique Hopitaux De Marseille
- Treatment: Zovirax · Ligand Pharms
- Treatment: ACYC · Ligand Pharms
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing